A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088
A Phase 1 Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088
Sponsor: AbbVie
Terminated
Strategic considerations
Other terminated trials from AbbVie
Other Healthy Volunteer trials with similar outcome
This PHASE1 trial investigates Healthy Volunteer and is currently terminated or withdrawn. AbbVie leads this study, which shows 7 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Nov 2025 — Present [monthly]
Terminated PHASE1
Status: Suspended → Terminated
-
Oct 2025 — Nov 2025 [monthly]
Suspended PHASE1
Status: Active Not Recruiting → Suspended
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jul 2025 — Sep 2025 [monthly]
Recruiting PHASE1
-
Jun 2025 — Jul 2025 [monthly]
Recruiting PHASE1
▶ Show 2 earlier versions
-
Oct 2024 — Jun 2025 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- AbbVie
For direct contact, visit the study record on ClinicalTrials.gov .